These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 6037526)

  • 21. Evidence for GABA-BZ receptor modulation in short-term memory passive avoidance task paradigm in mice.
    Sharma AC; Kulkarni SK
    Methods Find Exp Clin Pharmacol; 1990 Apr; 12(3):175-80. PubMed ID: 2161973
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The effects of aniracetam on primate behavior and EEG.
    Schwam E; Keim K; Cumin R; Gamzu E; Sepinwall J
    Ann N Y Acad Sci; 1985; 444():482-4. PubMed ID: 3860103
    [No Abstract]   [Full Text] [Related]  

  • 23. Blockade of conditioned taste aversion by scopolamine and N-methyl scopolamine: associative conditioning, not amnesia.
    Evenden JL; Lavis L; Iversen SD
    Psychopharmacology (Berl); 1992; 106(2):179-88. PubMed ID: 1312728
    [TBL] [Abstract][Full Text] [Related]  

  • 24. 5-HT1A and muscarinic acetylcholine receptors jointly regulate passive avoidance behavior.
    Riekkinen P
    Eur J Pharmacol; 1994 Sep; 262(1-2):77-90. PubMed ID: 7813581
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Involvement of AChergic systems in chlordiazepoxide induced impairment of passive avoidance response.
    Nabeshima T; Tohyama K; Kameyama T
    Neurosci Lett; 1990 Sep; 117(1-2):200-6. PubMed ID: 2290617
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of N-hydroxyethyl-pyrrolidinium methiodide, a choline analogue, on passive avoidance behaviour in mice.
    Glick SD; Crane AM; Barker LA; Mittag TW
    Neuropharmacology; 1975 Aug; 14(8):561-4. PubMed ID: 1178112
    [No Abstract]   [Full Text] [Related]  

  • 27. Differential effects of scopolamine and mecamylamine on passive avoidance behavior.
    Glick SD; Greenstein S
    Life Sci I; 1972 Feb; 11(4):169-79. PubMed ID: 4653199
    [No Abstract]   [Full Text] [Related]  

  • 28. Modulation of cholinergic activity and the aversive threshold in the rat.
    Houser VP; Van Hart DA
    Pharmacol Biochem Behav; 1974; 2(5):631-7. PubMed ID: 4431827
    [No Abstract]   [Full Text] [Related]  

  • 29. Effects of anticholinergic and cholinesterase blocking drugs on appetitive behavior under different deprivation conditions.
    Adams PM
    Life Sci; 1977 Jul; 21(1):129-36. PubMed ID: 886911
    [No Abstract]   [Full Text] [Related]  

  • 30. [Behavioral effects of propentofylline (HWA 285) on ambulatory activity, discrete avoidance response and passive avoidance response in mice].
    Kuribara H; Tadokoro S; Haraguchi H
    Nihon Yakurigaku Zasshi; 1986 May; 87(5):573-81. PubMed ID: 3732965
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cholinergic and anticholinergic influences on amphetamine-induced stereotyped behavior.
    Klawans HL; Rubovits R; Patel BC; Weiner WJ
    J Neurol Sci; 1972 Nov; 17(3):303-8. PubMed ID: 4653965
    [No Abstract]   [Full Text] [Related]  

  • 32. Effects of scopolamine on activity and passive avoidance learning in rats of different ages.
    Feigley DA
    J Comp Physiol Psychol; 1974 Jul; 87(1):26-36. PubMed ID: 4413163
    [No Abstract]   [Full Text] [Related]  

  • 33. Influence of recall on an anticholinesterase induced retrograde amnesia.
    Hamburg MD; Fulton DR
    Physiol Behav; 1972 Sep; 9(3):409-18. PubMed ID: 4676466
    [No Abstract]   [Full Text] [Related]  

  • 34. Chin rub CRs are elicited by flavors associated with apomorphine, scopolamine, methscopolamine, physostigmine and neostigmine.
    Smith RJ; Parker LA
    Pharmacol Biochem Behav; 1985 Oct; 23(4):583-9. PubMed ID: 4070336
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of cholinergic drugs on poor performance of rats in a shuttle-box.
    Rech RH
    Psychopharmacologia; 1968; 12(5):371-83. PubMed ID: 5723186
    [No Abstract]   [Full Text] [Related]  

  • 36. The effect of scopolamine on the amnesia induced by electroconvulsive shock.
    Albert DJ; mah CJ; Bose WB
    Pharmacol Biochem Behav; 1974 May; 2(3):443-6. PubMed ID: 4858182
    [No Abstract]   [Full Text] [Related]  

  • 37. The effect of D-amphetamine and physostigmine upon acquisition and retrieval in a single trial learning task.
    Bohdanecky Z; Jarvik ME
    Arch Int Pharmacodyn Ther; 1967 Nov; 170(1):58-65. PubMed ID: 6056593
    [No Abstract]   [Full Text] [Related]  

  • 38. Time-dependent changes in the effects of cholinesterase inhibitors on shuttle-box avoidance.
    Gonzalez LP; Altshuler HL
    Pharmacol Biochem Behav; 1980 Jun; 12(6):847-50. PubMed ID: 7403203
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Memory modulation with peripherally acting cholinergic drugs.
    Rush DK; Streit K
    Psychopharmacology (Berl); 1992; 106(3):375-82. PubMed ID: 1570386
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Possible involvement of brain somatostatin in the memory formation of rats and the cognitive enhancing action of FR121196 in passive avoidance task.
    Matsuoka N; Maeda N; Yamaguchi I; Satoh M
    Brain Res; 1994 Apr; 642(1-2):11-9. PubMed ID: 7913390
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.